WO2005084613A1 - Skin preparation for external use - Google Patents
Skin preparation for external use Download PDFInfo
- Publication number
- WO2005084613A1 WO2005084613A1 PCT/JP2004/002766 JP2004002766W WO2005084613A1 WO 2005084613 A1 WO2005084613 A1 WO 2005084613A1 JP 2004002766 W JP2004002766 W JP 2004002766W WO 2005084613 A1 WO2005084613 A1 WO 2005084613A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- extract
- konkon
- external preparation
- hexane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
Definitions
- the present invention percutaneously penetrates into the skin by applying, soaking, rubbing, or contacting the skin, reducing the amount of stains and freckles already formed,
- the present invention relates to an external preparation for skin used to regain the color of the skin, and to a basic external preparation such as cosmetic water and cosmetic cream, and a skin external preparation used as a bath and medical soap.
- Its purpose is to protect the skin from the ultraviolet rays that increase due to the recent stratospheric ozone depletion, prevent skin aging and darkening, and restore skin's original beauty by eliminating spots, sonogas, and dullness.
- Demand for basic whitening cosmetics has increased.
- women who had been tanned by irradiating ultraviolet light for the blackheads that were prevalent in the 1990s began to shift to the whitening trend, and the stains that remained after the sunburn had subsided. There is a strong demand for removing freckles.
- Cosmetic products for whitening include those that try to improve the dullness due to aging of the skin by suppressing the production of pigments due to active oxygen generated by ultraviolet irradiation, and the melanin-forming reaction that causes spots. Some try to reduce spots by inhibiting the activity of the chin mouth synase, which partially catalyzes.
- cosmetics containing antioxidants such as vitamin C, tocopherol (vitamin E), and superoxide dismutase (SOD) are being sold.
- Vitamins such as vitamins C and E generally have poor stability, and oxidized vitamin A and oxidized vitamin E generated after being oxidized with active oxygen have a negative effect, so they are satisfactory in terms of whitening. It cannot be done. Synthetic antioxidants with good stability tend to be shunned in recent years by consumers for safety, nature and health.
- Japanese Patent Application Laid-Open No. 6-227960 discloses a skin cosmetic containing a crude drug extract such as coconut and cypress as an inhibitor of melanin production based on tyrosinase f tongue inhibition.
- Japanese Patent Application Laid-Open No. 2002-121144 discloses that crude drug extracts such as bread corn, cowpea, and radish are excellent in preventing the oxidation of unsaturated fatty acids and eliminating active oxygen, and the external preparation for skin containing these is effective in improving dullness. Is superior to vitamin E.
- the extract of van radish used here is a hot water extract of the rhizome, an ethanol extract of the whole plant, and an extract of 1,3-butylene recall of the rhizome, and the excellent antioxidant effect of the extract It is intended to improve skin, firmness, and even dullness of the skin.
- Japanese Patent Application Laid-Open No. 2002-212052 discloses water-soluble thickeners such as glycerin hyaluronate Na, antibacterial alcohols such as ethanol, antioxidant vitamins such as tocofunicole, mefenamic acid and tranexam.
- a cosmetic composition containing an anti-inflammatory agent such as an acid and a plant extract such as ozone, button, aloe, carrot, and corn as a whitening component. This patent document shows that the pigmentation induced by ultraviolet light disappears, but the role of the fit substance on its action and effect is not evident.
- talcumin contained in the root rhizome extract of konkon has an antioxidant effect.
- (Supervised by Hideharu Itokawa, "The great effect of konkon,” Sora Publishing, June 22, 2001, 10th printing, 20-34 JP-A-2001-139466 and JP-A-2002-80338 disclose cosmetics utilizing a salt or derivative of talcumin which acts as an inhibitor of the activity of matritus proteases (collagenase, gelatinase, etc.). Proposed.
- the cosmetics disclosed herein are intended to prevent degradation of fiber proteins such as elastin related to aging of the skin, and to improve skin, tarmi, and dullness of the skin.
- the scavenging of active oxygen by the antioxidant component is intended to suppress the formation of spots and freckles due to ultraviolet irradiation, and further reduces the whitening effect of reducing, eliminating, and fading stains and freckles already formed. Improvement is desired.
- various cosmetics utilizing the effect of konkon extract on the skin and skin have been disclosed, but the mechanism of the effect is still unclear, and the effect varies depending on the extraction method and the composition of the extract. There is. Disclosure of the invention
- the present invention has been made as a result of detecting the active ingredients for whitening and the method for extracting whitening, and the object of the present invention is to reduce sunburn due to ultraviolet irradiation, stains and freckles due to aging, fading, and erasing.
- An object of the present invention is to provide a skin external preparation that restores the original color and shine of the skin to achieve whitening and beautiful skin.
- the external preparation for skin of the present invention contains, as an active ingredient, at least one selected from the group consisting of curdion, krugmole, neognoresion, and curcumenone.
- a skin external preparation according to another aspect of the present invention contains konkon (Curuc ui mae R hizoma) leaf extract, and particularly preferably contains an extract obtained by extracting konkon leaf with a hydrophobic organic solvent. .
- a whitening agent for skin containing 0.5 to 5% by mass of culdione and 0.5 to 5% by mass of talcumol, for example, extracted with a mixture of water and ethanol. Is contained in an amount of 1 to 20% by mass.
- the present invention further provides a cosmetic containing the above-mentioned external preparation for skin or a skin whitening agent of the present invention as a cosmetic capable of achieving skin whitening and skin whitening.
- the present invention provides an extraction method including a step of extracting a whitening component from a powdered coconut leaf, and a step of extracting the coconut leaf with a hydrophobic organic solvent.
- the external preparation for skin of the present invention is transdermally taken into the skin, inhibits the activity of tyrosinase in the reaction pathway shown in FIG. 1, and thereby suppresses the production of melanin which causes stains.
- it can be expected to fade and reduce the stains and freckles that have already formed along with the turnover of the skin, so it is effective as a skin-whitening essence to be used in cosmetics and bath salts.
- the external preparation for skin of the present invention has a bacterial activity, it is also effective in preventing sebaceous skin from dermatitis.
- FIG. 1 is a schematic diagram of a reaction path for explaining a mechanism of melanin production.
- FIG. 2 is a schematic diagram of a reaction path for explaining the principle of measuring the effect of removing active oxygen.
- FIG. 3 is a gas chromatography of a hexane extract of coconut leaves.
- FIG. 4 is a mass spectrum of peak component 2 in the gas chromatography shown in FIG.
- FIG. 5 is a mass spectrum of the peak component 6 in the gas chromatography shown in FIG.
- FIG. 6 is a mass spectrum of peak component 1 in the gas chromatography shown in FIG.
- FIG. 7 is a mass spectrum of peak component 3 in the gas chromatography of FIG.
- FIG. 8 is a dendrogram showing the tyrosinase activity inhibition rate and SOD activity in each fraction of the icon leaf extract.
- the external preparation for skin of the present invention contains, as an active ingredient, at least one selected from the group consisting of curdion, talcumol, neocurdione, and curcumenone. These compounds may be synthetic or may be extracts from natural products.
- cruzione means 1 (10) -germacrene-5,8-dione represented by the following chemical formula (1).
- Clecmonore is a compound represented by the following chemical formula (2).
- Talcmenone is a compound represented by the following chemical formula (3)
- Neoculdione is a compound represented by the following chemical formula (4).
- curdion and curcumol are antibacterial against various bacteria such as Escherichiacoli, Bacillus subtilis (Baci 11 ussubti 1 is), and Bacillus subtilis (Pseudomo nasaeruginosa). have.
- the external preparation for skin of the present invention may contain only one of the above active ingredients, but preferably contains all of them.
- ⁇ kon Leaf Extract contains cruzi ⁇ ", It contains talc mall, neocludion, and curcumenone, so it is easy and convenient to obtain.
- ⁇ kon refers to the scientific name rcurcumae R izomaJ, which is generally called autumn cum (Cucuma longa) and spring apple (curcuma aromatica).
- radish extract has been known to have a bile effect of its rhizome extract and its main component, curcumin (see Nanedo Co., Ltd., Revised 4th Edition of Pharmaceutical Sciences) and has been used as a crude drug.
- curcumin has been used as an active ingredient such as an antioxidant in cosmetics, an anti-inflammatory agent, and a whitening ingredient, utilizing the antioxidant action of curcumin and the anti-inflammatory action of rhizome extract. Its efficacy is not known and it has been discarded.
- the components of the essential oil extracted from the leaves of the konkon are different from the rhizome extract composition.
- Gas chromatography Matogurafi first and mass spectral analysis of the results the components of the content of 1 mass 0/0 or more Ukon leaf extract component is 1, 8-Shineroru, Renaruru, a- Terubineoru, caryophyllene oxa Lee de, Kurujion, Gerumaku port down state, and are talc Mall, the content of Kurujion and talc mall is about 5 0 weight 0/0. In addition to these, it contains neocurdione and curcumenone as trace components.
- the konkon leaf extract contains a high proportion of the effective ingredients for the skin, such as curdion and curcumol, and also contains the effective ingredients such as neocurdione and talcumnone. It is more convenient to include konkon leaf extract than to include it. In addition to the effective use of konkon leaf that had been discarded in the past, ⁇ the effect of plus alfa based on minerals (such as terpenes) and minerals other than the above-mentioned active ingredients contained in konkon leaf extract. Can be expected.
- the extraction solvent used for obtaining the konkon leaf extract containing the active ingredient as described above may be selected in consideration of the purpose of use, the type of the product to be provided, the processing to be performed later, and the like.
- knollezion, talcumol, neoculdione, and talcumenone which are active ingredients for whitening, all have high solubility in hydrophobic organic solvents such as hexane, so that an extract with a high content of these whitening components is necessary to obtain an extract with a high content of these whitening components.
- Extraction is preferably performed using a hydrophobic organic solvent, preferably one selected from the group consisting of hexane, getyl ether and ethyl acetate, or a mixture thereof, and more preferably hexane.
- the extraction may be performed in multiple stages, for example, extraction of coconut leaf powder with methanol followed by extraction with hexane.However, in order to increase the content of whitening components, hydrophobic organic It is preferable to include an extraction step with a solvent.
- the extract-containing solution extracted with these solvents may be used as it is as an external preparation for the skin, or may be used after being subjected to treatments such as concentration, dilution, filtration, and drying as needed. After the extraction, the beaded aqueous organic solvent may be volatilized by drying or the like to obtain a powder having a high whitening component content.
- the extract when the extract is contained in an external preparation for skin together with an extraction solvent, it is preferable to use low-grade alcohol, water or a mixture thereof, particularly a mixture of water and ethanol as the extraction solvent.
- the external preparation for skin of the present invention uses curdion, curcumol, neocurdione, a synthetic product of talc-menone, an isolated product from natural products, or konjac leaf extract, which may be contained in an appropriate solvent or base. As an additive, it may be added to cosmetics or quasi-drugs. The content is appropriately selected according to the final product.
- Final products include skin cleansing creams, cleansing lotions, facial cleansers, soaps, and other skin cleansing agents in addition to skin agents, lotions, and cosmetic creams; skin conditioners such as moisturizing lotions, soft lotions, and astringent lotions.
- Protective agents such as milky lotions, emollient milks, and vanishing creams; activators such as massage creams, massage lotions, foam packs, and peel-off packs; bath salts; and poultices.
- the active ingredient is transdermally incorporated into the skin, It can work for fading, reducing and disappearing.
- the skin external preparation of the present invention is a solid that does not impair the effect of the extract. It can contain humectants, UV absorbers, thickeners, dyes, antioxidants, and chelating components.
- Oil bases include beeswax and cocoa oil; carnapa wax, higher fatty acids, solid paraffin, solid oily raw materials such as cetyl alcohol, stearyl alcohol; semi-solid oily raw materials such as serine and lanolin; squalane, olive oil; Castor oil, palm oil, peanut oil, liquid paraffin, oleic acid, linoleic acid, octyldodecyl myristate, silicone oil and the like can be used.
- aqueous base examples include humectants such as glycerin, sorbitol, polyethylene glycol, pyrrolidone carboxylic acid and its salts, collagen, hyaluronic acid and its salts, chondroitin sulfate and its salts; carboxymethyl cellulose sodium, polyvinyl alcohol Thickeners such as Ni / Rare Coal ', xanthan gum, canoleboxybininole polymer, hydroxypropyl cellulose, and gum arabic are used.
- humectants such as glycerin, sorbitol, polyethylene glycol, pyrrolidone carboxylic acid and its salts, collagen, hyaluronic acid and its salts, chondroitin sulfate and its salts
- carboxymethyl cellulose sodium polyvinyl alcohol Thickeners such as Ni / Rare Coal ', xanthan gum, canoleboxybininole polymer, hydroxypropyl
- surfactant examples include nonionic surfactants such as polyethylene glycol isostearate, sorbitan stearate, glycerin fatty acid ester, polyoxyethylene hexylde, and silyl ether; vanionics such as sodium lauryl sulfate and sodium lauryl phosphate; Cationic surfactants such as stearyldimethylbenzylammonium chloride; natural surfactants such as sucrose fatty acid ester, casein sodium, lecithin, and collagen are used.
- nonionic surfactants such as polyethylene glycol isostearate, sorbitan stearate, glycerin fatty acid ester, polyoxyethylene hexylde, and silyl ether
- vanionics such as sodium lauryl sulfate and sodium lauryl phosphate
- Cationic surfactants such as stearyldimethylbenzylammonium chloride
- natural surfactants such as sucrose fatty acid este
- pH adjuster examples include potassium carbonate, sodium hydrogen carbonate, and ammonium hydrogen carbonate.
- UV absorbers preservatives such as ethyl paraben and butyl paraben; anti-inflammatory agents such as glycyrrhizic acid derivatives, glycinoleretinic acid derivatives, salicylic acid derivatives, hinokitiol, zinc oxide, allantoin; vitamins such as retinol noremitinate Antioxidants such as vitamin Bs such as riboflavin and nicotinic acid amide, vitamin Ds such as cholecalciferol, d1—vitamin E such as 1-tocopherol; sodium erythorbic acid.
- preservatives such as ethyl paraben and butyl paraben
- anti-inflammatory agents such as glycyrrhizic acid derivatives, glycinoleretinic acid derivatives, salicylic acid derivatives, hinokitiol, zinc oxide, allantoin
- vitamins such as retinol noremitinate
- Antioxidants such as vitamin Bs such
- Antioxidants such as sage extract and parahydroxydisole; activators such as royal jelly and cholesterol derivatives; various amino acids; blood circulation promoters such as ⁇ - oryzanol, dextran sodium sulfate; coloring agents such as titanium yellow, carsamin and safflower; Other plant extracts are included.
- the skin whitening agent of the present invention is a cosmetic or quasi-drug mainly for skin whitening, among skin external preparations, and contains 0.5 to 5% by mass of curdion and 0.5 to 5% by mass of curcumol. .
- konkon leaf extract is contained in an amount of 1 to 20% by mass, depending on the extraction method. ⁇
- the skin lightening agent is a lotion
- it is diluted with purified water, and if necessary, the above-mentioned humectant, thickener, pH regulator, preservative, fragrance, oxidation
- an inhibitor e.g., a surfactant, an ultraviolet absorber, etc.
- an oily base and an aqueous base may be used as appropriate instead of purified water.
- the leaf powder of spring corn, produced by Oki Silk was immersed in 30% ethanol for 2 days and then filtered. The residue was immersed again in 30% ethanol for 2 days and filtered. The obtained filtrate (ethanol extract) was concentrated under reduced pressure, sterilized by heating at 80 ° C, cooled, and filtered to obtain a corn leaf extract. 200 g of this konkon leaf extract was dissolved in 30% ethanol water to make a 1 liter solution (containment of konkon leaf extract: 20%).
- the root powder of spring corn produced in Oki was immersed in 30% ethanol for 2 days and then filtered. The residue was immersed again in 30% ethanol for 2 days and filtered. The resulting filtrate (e) The ethanol extract was concentrated under reduced pressure, sterilized by heating at 80 ° C, cooled, and filtered to obtain a root extract. 200 g of the konkon root extract was dissolved in 30% ethanol water to make a 1 liter solution (20% konkon root extract content).
- the active oxygen remover was measured for N. leaf extract No. 1 and N. root extract by NBT test.
- the NBT test consists of a coloring reagent (phosphate buffer of pH 8.0 containing 0.24 mM of nitro blue tetrazolium (NBT) and 0.4 mM of xanthine) and an enzyme solution (0.049 U / ml of xanthinoxidase). Is added to the sample solution, and the amount of diformazan generated by the reaction shown in Fig. 2 is measured to determine the amount of xanthine (the active oxygen radicals generated by O-oxidation). The more hydrogen ions (active oxygen radical scavenging function), the smaller the amount of NBT converted to diformazan.
- a coloring reagent phosphate buffer of pH 8.0 containing 0.24 mM of nitro blue tetrazolium (NBT) and 0.4 mM of xanthine
- an enzyme solution 0.049 U / ml of xanthinoxidase
- the absorbance at 560 nin (EB 1 ) when the enzyme solution was added using 10 ⁇ l of distilled water instead of the sample aqueous solution and the black solution was used instead of the enzyme solution absorbance at 56011111 £] ⁇ 1 was measured.
- the active oxygen removal rate was determined based on the following equation.
- Active oxygen removal rate U— (E S -E SB1 ) ⁇ (E B1 — E BB1 ) ⁇ xl 00 ⁇
- Container leaf extract No. 1 has an active oxygen removal rate of 34.4%, indicating that the activity of ⁇ The oxygen removal rate was 63%. ⁇ It can be said that the active oxygen removal function of konkon leaf extract is lower than that of konkon root extract. ⁇ Concrete root extract contains curcumin, which generates hydrogen ions. ⁇ ⁇ It is probable that crucade and knorecmol, which are the main components of konkon leaf extract, are not expected to generate any x-radicals. (Tyrosinase activity inhibitory action)
- the konkon leaf extract No. 1 and the konkon root extract were examined for their inhibitory effect on the activity of tyroxynase, an enzyme involved in melanin production.
- the measurement was carried out using an enzyme solution (0.1 unit Zmg, 10%) and a phosphate buffer solution (L-DOPA (L-dihydroxyphenylalanine)) maintained at pH 6-6.2 as a substrate.
- L-DOPA Li-dihydroxyphenylalanine
- the sample solution was ⁇ Ka ⁇
- the dopaquinone This was performed by measuring the amount of production.
- L-DOPA reacts as shown in Fig. 1 to produce dopaquinone, a source of melanin production, and tyrosinase enzymes are involved in this reaction. Therefore, the sample inhibits the tyrosinase enzyme reaction, thereby reducing the amount of dopaquinone produced and consequently the melanin production can be suppressed.
- tyrosinase enzyme solution a filtrate obtained by subjecting a suspension obtained by calorizing a phosphate buffer solution to 10 g of phosphate buffer to 1 g of acetone powder prepared from potato tubers to obtain a suction solution was used.
- the absorbance (B) was measured at 40 nm using a phosphate buffer instead of the sample solution and the substrate as a blank.
- the tyrosinase inhibition rate was calculated by the following equation.
- Tyrosinase inhibition rate (B-S) / ⁇ 100
- the tyrosinase activity inhibition rate of ⁇ kon leaf extract ⁇ ⁇ .1 was 14.9% and the tyrosinase activity inhibition rate of ⁇ konkon root extract was 7.7%. It can be seen that the ⁇ kon leaf extract has about twice the tyrosinase activity inhibitory effect of the ⁇ kon root extract.
- fraction 3 was subjected to silica gel chromatography and fractionated into three fractions using a solvent in which hexane and ethyl acetate were mixed at a ratio of 10: 1 (fraction 4:24 mg, fraction 5:15 mg, fraction 5:15 mg, 6:29 mg], 1.2 mg of neocurdione from fraction 4, and 12 mg of curcumonele from fraction 5.
- the tyrosinase activity of each of the white crystals of Culdione and Talcmol was measured according to the method described above. Note that none of these crystals was soluble in water; they were dissolved in a small amount of dimethyl sulfoxide (DIMSO) and then dispersed in water to form a sample solution.
- DIMS dimethyl sulfoxide
- the tyrosinase inhibitory activity of the Culdione solution was 62.1%, and the tyrosinase inhibitory activity of the talcumone solution was 55.4%. [Effect as lotion]
- the corn extract No. 1 was diluted with purified water to prepare a 2% lotion of konkon leaf extract.
- Paneler 3 (five-year-old woman) Spots decreased to less than half in about two months.
- Paneler 4 male aged 46 Sobacas decreased to around 1Z4 in about one month.
- Paneler 5 (37-year-old woman) The pores are no longer darkened.
- the lotion of the present invention is effective in fading, reducing and eliminating stains and freckles.
- Paneler 5 is not a stain or buckwheat, but it can be seen that the skin lotion of the present invention has a whitening effect such as reduced blackening and pigment fading.
- Paneler 6 does not have a whitening effect such as pigment fading, but it is thought to be due to the antibacterial effect of the extract of konkon leaf.
- the obtained methanol extract was separated into a hexane layer and a methanol layer using 1 liter of hexane, and each layer was concentrated under reduced pressure to obtain 38.7971 g of the hexane extract. And 49.938 g of methanol extract.
- Antibacterial activity of both hexane and methanol extracts by paper disk method using E. coli as an indicator When the activity was examined, no antibacterial activity was observed in the methanol extract, and antibacterial activity was observed in the hexane extract.
- the hexane extract was subjected to steam distillation to obtain 0.323 g of an essential oil component.
- an antibacterial test was performed using Escherichia coli as an indicator, DMS ⁇ as a negative control using a microplate method, and benzoic acid as a positive control. Indicated.
- the hexane extract was subjected to silica gel chromatography to obtain a curdion-containing fraction and a curcumol-containing fraction.
- antibacterial activity against various bacteria was examined by the paper disk method and the microplate method. The results are shown in Table 2 (paper disc method) and Table 3 (microplate method).
- the skin external preparation of the present invention has a high tyrosinase activity inhibitory activity and also has an antibacterial activity, it is used as a skin external preparation for the purpose of whitening cosmetics, prevention of acne and spots and treatment. be able to.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
明 細 書 皮膚外用剤 技術分野 Description Skin external preparation Technical field
本発明は、 皮膚に塗ったり、 染みこませたり、 擦ったり、 接触させたりするこ とによって経皮的に皮膚内部へ浸透させ、 既にできたシミ、 ソバカス等を低減、 退色させて、 本来の皮膚の色を取り戻すために用いられる皮膚外用剤に関し、 化 粧水、 化粧クリーム等の基礎化粧品や入浴 リ、 薬用石けん等として用いられる皮 膚外用剤に関する。 背景技術 The present invention percutaneously penetrates into the skin by applying, soaking, rubbing, or contacting the skin, reducing the amount of stains and freckles already formed, The present invention relates to an external preparation for skin used to regain the color of the skin, and to a basic external preparation such as cosmetic water and cosmetic cream, and a skin external preparation used as a bath and medical soap. Background art
近年の成層圏オゾン層の破壌に基づいて増加する紫外線から肌を守り、 皮膚の 老化、 黒化を防止するとともに、 シミ、 ソノ カス、 くすみをなくして皮膚本来の 美しさを取り戻すことを目的とした美白用基礎化粧品の需要が高まっている。 特 に、 1 9 9 0年代に流行した顔黒のために、 紫外線を照射して日焼けさせた女性 たちが、 美白化の流行に転換するようにな り、 日焼けがおさまった後に残ったシ ミ、 ソバカスを取り除くことについて、 強い要望がある。 Its purpose is to protect the skin from the ultraviolet rays that increase due to the recent stratospheric ozone depletion, prevent skin aging and darkening, and restore skin's original beauty by eliminating spots, sonogas, and dullness. Demand for basic whitening cosmetics has increased. In particular, women who had been tanned by irradiating ultraviolet light for the blackheads that were prevalent in the 1990s began to shift to the whitening trend, and the stains that remained after the sunburn had subsided. There is a strong demand for removing freckles.
美白用化粧品としては、 紫外線照射によ り生じる活性酸素による色素産生を抑 制して、 肌の老化に伴うくすみを改善しよ うとするものや、 シミの原因となるメ ラ二ン生成反応の一部を触媒するチ口シナーゼ活性を阻害することによりシミ を低減しょうとするものがある。 前者の化驅品としては、 ビタミン C、 トコフエ ロール (ビタミン E ) 、 スーパ一ォキシドジスムターゼ ( S O D ) 等の抗酸化剤 を含有させた化粧品が販売されている。 し力、し、 ビタミン C、 E等のビタミン類 は、 一般に安定性が悪く、 また活性酸素で酸化された後に生じる酸化型ビタミン A、 酸化型ビタミン Eが悪影響を及ぼすため、 美白という点では満足できるもの ではない。 安定性に優れた合成抗酸化剤は、 近年の消費者の安全性志向、 自然志 向、 健康志向から、 敬遠される傾向にある。 Cosmetic products for whitening include those that try to improve the dullness due to aging of the skin by suppressing the production of pigments due to active oxygen generated by ultraviolet irradiation, and the melanin-forming reaction that causes spots. Some try to reduce spots by inhibiting the activity of the chin mouth synase, which partially catalyzes. As the former chemical products, cosmetics containing antioxidants such as vitamin C, tocopherol (vitamin E), and superoxide dismutase (SOD) are being sold. Vitamins such as vitamins C and E generally have poor stability, and oxidized vitamin A and oxidized vitamin E generated after being oxidized with active oxygen have a negative effect, so they are satisfactory in terms of whitening. It cannot be done. Synthetic antioxidants with good stability tend to be shunned in recent years by consumers for safety, nature and health.
自然派化粧品を好む消費者の要望に応えるべく、 美肌、 美白化に有用な成分と して、 ハーブエキス又は生薬エキスを使用した美白用自然派化粧品が提案されて いる。 In order to meet the demands of consumers who prefer natural cosmetics, natural whitening cosmetics using herbal extracts or herbal extracts have been proposed as useful ingredients for skin and whitening. Yes.
例えば、 特開平 6— 227960号には、 チロシナーゼ f舌性阻害に基づくメラ ニン生成抑制剤として、 ゥコン、 チヨウジ等の生薬抽出物 含有する皮膚化粧料 が開示されている。 ここで用いられるゥコン抽出物は、 ゥ =rンの根茎部を水、 メ タノール、 ェタノール等の親水性有機溶剤で抽出した抽出 である。 For example, Japanese Patent Application Laid-Open No. 6-227960 discloses a skin cosmetic containing a crude drug extract such as coconut and cypress as an inhibitor of melanin production based on tyrosinase f tongue inhibition. The radish extract used here is an extract obtained by extracting the rhizome of ゥ = r with a hydrophilic organic solvent such as water, methanol or ethanol.
特開平 2002- 1 21 144号には、 パンゥコン、 ササゲ、 ヮサビノキ等の 生薬抽出物が不飽和脂肪酸酸化防止作用及び活性酸素消去 f乍用に優れ、 これらを 含有する皮膚外用剤がくすみ改善に対してビタミン Eよりも優れていることが 開示されている。 ここで用いられているバンゥコンの抽出物は、 地下茎の熱水抽 出物、 全草のエタノール抽出物、 地下茎の 1, 3ブチレン "リコールの抽出物で あり、 当該抽出物の優れた抗酸化作用により、 シヮ、 ハリ、 さらには肌のくすみ を改善しようとするものである。 Japanese Patent Application Laid-Open No. 2002-121144 discloses that crude drug extracts such as bread corn, cowpea, and radish are excellent in preventing the oxidation of unsaturated fatty acids and eliminating active oxygen, and the external preparation for skin containing these is effective in improving dullness. Is superior to vitamin E. The extract of van radish used here is a hot water extract of the rhizome, an ethanol extract of the whole plant, and an extract of 1,3-butylene recall of the rhizome, and the excellent antioxidant effect of the extract It is intended to improve skin, firmness, and even dullness of the skin.
特開 2002-21 2052号には、 グリセリンゃヒア zレロン酸 N a等の水溶 性増粘剤、 エタノール等の抗菌性アルコール、 トコフニ口一ル類等の抗酸化ビタ ミン類、メフヱナム酸やトラネキサム酸等の抗炎症剤とと に、美白成分として、 ォゥゴン、 ボタン、 アロエ、 にんじん、 ゥコン等の植物抽 tH物を添加した化粧用 組成物が開示されている。 この特許文献には、 紫外線によ 惹起された色素沈着 が消退することが示されているが、 その作用効果に対する fit物ェキスの役割は明 らカ こされていない。 Japanese Patent Application Laid-Open No. 2002-212052 discloses water-soluble thickeners such as glycerin hyaluronate Na, antibacterial alcohols such as ethanol, antioxidant vitamins such as tocofunicole, mefenamic acid and tranexam. There is disclosed a cosmetic composition containing an anti-inflammatory agent such as an acid and a plant extract such as ozone, button, aloe, carrot, and corn as a whitening component. This patent document shows that the pigmentation induced by ultraviolet light disappears, but the role of the fit substance on its action and effect is not evident.
一方、 ゥコンの根茎抽出物に含まれるタルクミンが抗酸 ヒ作用を有することが 知られており (糸川秀治監修 「ゥコンの凄い特効」 宙出版、 2001年 6月 22 日第 10刷、 20— 34頁) 、 特開 2001— 1 39466号、 特開 2002— 80338号では、タルクミンの塩又は誘導体が、マトリツ タスプロテアーゼ(コ ラゲナーゼ、 ゼラチナーゼなど) の活性阻害剤として、 働くことを利用した化粧 品が提案されている。 ここで開示されている化粧品は、 皮膚の老化に関連するェ ラスチン等の繊維タンパク質の分解を防止して、 シヮ、 タルミ、 肌のくすみを改 善しようとするものである。 On the other hand, it is known that talcumin contained in the root rhizome extract of konkon has an antioxidant effect. (Supervised by Hideharu Itokawa, "The great effect of konkon," Sora Publishing, June 22, 2001, 10th printing, 20-34 JP-A-2001-139466 and JP-A-2002-80338 disclose cosmetics utilizing a salt or derivative of talcumin which acts as an inhibitor of the activity of matritus proteases (collagenase, gelatinase, etc.). Proposed. The cosmetics disclosed herein are intended to prevent degradation of fiber proteins such as elastin related to aging of the skin, and to improve skin, tarmi, and dullness of the skin.
抗酸化成分による活性酸素の捕捉は、 紫外線照射によるシミ、 ソバカスの新生 を抑制しょうとするものであり、 既にできているシミ、 ソバカスの低減、 消失、 退色といった美白効果に対しては、 更なる向上が望まれてレ、る。 一方、 上述のように、 肌、 皮膚に対するゥコンエキスの効果を利用する化粧品 は、 種々開示されているものの、 その作用効果のメカニズムは だ明らかではな く、 抽出方法、 エキスの組成によっても効果にばらつきがある。 発明の開示 The scavenging of active oxygen by the antioxidant component is intended to suppress the formation of spots and freckles due to ultraviolet irradiation, and further reduces the whitening effect of reducing, eliminating, and fading stains and freckles already formed. Improvement is desired. On the other hand, as described above, various cosmetics utilizing the effect of konkon extract on the skin and skin have been disclosed, but the mechanism of the effect is still unclear, and the effect varies depending on the extraction method and the composition of the extract. There is. Disclosure of the invention
本発明は、 ゥコンの抽出方法、 美白化に対する有効成分を検 H"した結果なされ たもので、本発明の目的は、紫外線照射による日焼けをはじめ、老化に伴うシミ、 ソバカスの低減、 退色、 消去により皮膚本来の色、 艷をよみがえらせて、 美白、 美肌を達成させる皮膚外用剤を提供することにある。 The present invention has been made as a result of detecting the active ingredients for whitening and the method for extracting whitening, and the object of the present invention is to reduce sunburn due to ultraviolet irradiation, stains and freckles due to aging, fading, and erasing. An object of the present invention is to provide a skin external preparation that restores the original color and shine of the skin to achieve whitening and beautiful skin.
本発明の皮膚外用剤は、 有効成分として、 クルジオン、 クルグモール、 ネオク ノレジオン、 及びクルクメノンからなる群より選ばれる少なくと 1種を含有する。 本発明の別の見地による皮膚外用剤は、 ゥコン (C u r u c ui m a e R h i z o m a ) 葉のエキスを含有するもので、 特にゥコン葉を疎水†生有機溶剤で抽出 した抽出物を含有することが好ましい。 また、 疎水性有機溶剤 f 、 へキサン、 ジ ェチルエーテル及び酢酸ェチルからなる群より選ばれる少なく とも 1種である ことが好ましい。 The external preparation for skin of the present invention contains, as an active ingredient, at least one selected from the group consisting of curdion, krugmole, neognoresion, and curcumenone. A skin external preparation according to another aspect of the present invention contains konkon (Curuc ui mae R hizoma) leaf extract, and particularly preferably contains an extract obtained by extracting konkon leaf with a hydrophobic organic solvent. . In addition, it is preferable that at least one selected from the group consisting of a hydrophobic organic solvent f, hexane, dimethyl ether and ethyl acetate is used.
本発明のさらに別の見地では、皮膚の美白剤で、クルジオンを O . 5〜5質量% 及びタルクモールを 0 . 5〜5質量%含有し、 例えば、 水及びエタノール混合物 で抽出したゥコン葉エキスを 1〜2 0質量%含有する。 In yet another aspect of the present invention, a whitening agent for skin, containing 0.5 to 5% by mass of culdione and 0.5 to 5% by mass of talcumol, for example, extracted with a mixture of water and ethanol. Is contained in an amount of 1 to 20% by mass.
本発明は、 さらに美白、 美肌を達成できる化粧料として、 上記本発明の皮膚外 用剤又は皮膚の美白剤を含有する化粧料を提供する。 The present invention further provides a cosmetic containing the above-mentioned external preparation for skin or a skin whitening agent of the present invention as a cosmetic capable of achieving skin whitening and skin whitening.
また本発明は、 ゥコン葉粉末から美白成分を抽出する方法で feつて、 ゥコン葉 を疎水性有機溶剤で抽出する工程を含む抽出方法を提供する。 In addition, the present invention provides an extraction method including a step of extracting a whitening component from a powdered coconut leaf, and a step of extracting the coconut leaf with a hydrophobic organic solvent.
本発明の皮膚外用剤は、 経皮的に皮膚内部に取り込まれて、 篛 1図に示す反応 経路において、 チロシナーゼの活性を阻害することにより、 シミの原因となるメ ラニンの生成を抑制し、 さらに皮膚のターンオーバーに伴って、 すでにできたシ ミ、 ソバカスの退色、 低減を期待できるので、 化粧料、 入浴剤 ίこ配合される美白 エッセンスとして有効である。 また、 本発明の皮膚外用剤は、 菌活性を有して いるので、 皮脂性の肌の二キビゃ化膿防止にも有効である。 図面の簡単な説明 The external preparation for skin of the present invention is transdermally taken into the skin, inhibits the activity of tyrosinase in the reaction pathway shown in FIG. 1, and thereby suppresses the production of melanin which causes stains. In addition, it can be expected to fade and reduce the stains and freckles that have already formed along with the turnover of the skin, so it is effective as a skin-whitening essence to be used in cosmetics and bath salts. Further, since the external preparation for skin of the present invention has a bacterial activity, it is also effective in preventing sebaceous skin from dermatitis. Brief Description of Drawings
第 1図は、 メラニン生成のメカニズムを説明するための反応経路概略図である。 第 2図は、 活性酸素除去効果の測定原理を説明するための反応経路概略図であ 第 3図は、 ゥコン葉のへキサン抽出液のガスクロマトグラフィーである。 FIG. 1 is a schematic diagram of a reaction path for explaining a mechanism of melanin production. FIG. 2 is a schematic diagram of a reaction path for explaining the principle of measuring the effect of removing active oxygen. FIG. 3 is a gas chromatography of a hexane extract of coconut leaves.
第 4図は、 第 3図のガスクロマトグラフィ一におけるピーク成分 2のマススぺ クトルである。 FIG. 4 is a mass spectrum of peak component 2 in the gas chromatography shown in FIG.
第 5図は、 第 3図のガスクロマトグラフィ一におけるピーク成分 6のマススぺ ク トルである。 FIG. 5 is a mass spectrum of the peak component 6 in the gas chromatography shown in FIG.
第 6図は、 第 3図のガスクロマトグラフィ一におけるピーク成分 1のマススぺ ク トルである。 FIG. 6 is a mass spectrum of peak component 1 in the gas chromatography shown in FIG.
第 7図は、 第 3図のガスクロマトグラフィ一におけるピーク成分 3のマススぺ ク トルである。 FIG. 7 is a mass spectrum of peak component 3 in the gas chromatography of FIG.
第 8図は、 ゥコン葉抽出液の各フラクションにおけるチロシナーゼ活性阻害率 及び S O D活性を示す樹状図である。 発明を実施するための最良の形態 FIG. 8 is a dendrogram showing the tyrosinase activity inhibition rate and SOD activity in each fraction of the icon leaf extract. BEST MODE FOR CARRYING OUT THE INVENTION
本発明の皮膚用外用剤は、 有効成分として、 クルジオン、 タルクモール、 ネオ クルジオン、 及びクルクメノンからなる群より選ばれる少なくとも 1種を含有す る。 これらの化合物は、 合成品であってもよいが、 天然物からの抽出物であって あよい。 The external preparation for skin of the present invention contains, as an active ingredient, at least one selected from the group consisting of curdion, talcumol, neocurdione, and curcumenone. These compounds may be synthetic or may be extracts from natural products.
ここで、 クルジオンとは、 下記化学式 ( 1 ) で示される 1 ( 1 0 ) —ゲルマク レン一5 , 8—ジオンをいう。 Here, the cruzione means 1 (10) -germacrene-5,8-dione represented by the following chemical formula (1).
ク レクモーノレとは 下記化学式 ( 2 ) で示される化合物である。 Clecmonore is a compound represented by the following chemical formula (2).
タルクメノンとは、 下記化学式 (3) で示される化合物である Talcmenone is a compound represented by the following chemical formula (3)
ネオクルジオンは、 下記化学式 (4) で示される化合物である。 Neoculdione is a compound represented by the following chemical formula (4).
これらの化合物は、 いずれも経皮透過性に優れ、 皮膚内部に浸透して、 誇 1図 に示す反応経路において、 チロシナーゼ活性を阻害し、 これによりメラニンの生 成を抑制することができる。 また、 クルジオン及びクルクモール、 特にクノレジオ ンは、 大腸菌 (E s c h e r i c h i a c o l i) , 枯草菌 (B a c i 1 1 u s s u b t i 1 i s ) 、 緑膽菌 (P s e u d omo n a s a e r u g i n o s a) 等の各種バクテリアゃカビ類に対して抗菌性を有している。 Each of these compounds has excellent transdermal permeability, penetrates into the skin, and inhibits tyrosinase activity in the reaction pathway shown in FIG. 1, thereby suppressing the production of melanin. In addition, curdion and curcumol, especially knollegion, are antibacterial against various bacteria such as Escherichiacoli, Bacillus subtilis (Baci 11 ussubti 1 is), and Bacillus subtilis (Pseudomo nasaeruginosa). have.
本発明の皮膚外用剤は、 上記有効成分を 1種だけ含有するものであって よい が、すべて含有することが好ましい。 この点、 ゥコン葉エキスには、クルジ^ "ン、 タルクモール、 ネオクルジオン、 クルクメノンがすべて含まれているので、 入手 容易かつ便利である。 The external preparation for skin of the present invention may contain only one of the above active ingredients, but preferably contains all of them. In this regard, ゥ kon Leaf Extract contains cruzi ^ ", It contains talc mall, neocludion, and curcumenone, so it is easy and convenient to obtain.
ここで、 「ゥコン」 とは、 学術名 rcurcumae R izomaJ で、 一般に秋ゥコン (鬱金: Curcuma longa) と呼ばれているもの及び春ゥコン (姜黄: Curcuma aromatica) と呼ばれているものをいう。 Here, “ゥ kon” refers to the scientific name rcurcumae R izomaJ, which is generally called autumn cum (Cucuma longa) and spring apple (curcuma aromatica).
従来より、 ゥコンについては、 その根茎エキス及びその主成分であるクルクミ ンの利胆作用が知られており (株式会社南江堂の生薬学改訂第 4版参照) 、 生薬 として用いられている。 また、 近年では、 クルクミンの抗酸化作用や根茎エキス の消炎作用を利用して、 化粧品の抗酸化剤ゃ抗炎症剤、 美白成分等の有効成分に も利用されているが、 葉エキスについては、 その効能は知られておらず、 廃棄さ れていたのが現状である。 Conventionally, radish extract has been known to have a bile effect of its rhizome extract and its main component, curcumin (see Nanedo Co., Ltd., Revised 4th Edition of Pharmaceutical Sciences) and has been used as a crude drug. In recent years, curcumin has been used as an active ingredient such as an antioxidant in cosmetics, an anti-inflammatory agent, and a whitening ingredient, utilizing the antioxidant action of curcumin and the anti-inflammatory action of rhizome extract. Its efficacy is not known and it has been discarded.
ゥコンの葉の抽出精油の成分は、 根茎抽出成分組成と異なっている。 ガスクロ マトグラフィ一及び質量スぺク トル分析の結果、 ゥコン葉抽出成分の含有率が 1 質量0 /0以上の成分は、 1, 8—シネロール、 レナルール、 a—テルビネオール、 カリオフィレンオキサイ ド、 クルジオン、 ゲルマク口ン、 タルクモールなどであ り、 クルジオン及びタルクモールの含有率は約 5 0質量0 /0である。 これらの他、 微量成分として、 ネオクルジオン、 クルクメノンを含んでいる。 成分 The components of the essential oil extracted from the leaves of the konkon are different from the rhizome extract composition. Gas chromatography Matogurafi first and mass spectral analysis of the results, the components of the content of 1 mass 0/0 or more Ukon leaf extract component is 1, 8-Shineroru, Renaruru, a- Terubineoru, caryophyllene oxa Lee de, Kurujion, Gerumaku port down state, and are talc Mall, the content of Kurujion and talc mall is about 5 0 weight 0/0. In addition to these, it contains neocurdione and curcumenone as trace components.
ゥコン葉抽出液の主成分であるクルジオンはゥコンの根茎エキスにはほとん ど含まれておらず、 逆に根茎エキスの有効成分として知られているクルクミンは. ゥコン葉エキスにはほとんど含有されていない。 ク ル Culdion, the main component of konkon leaf extract, is hardly contained in konkon rhizome extract, and conversely, curcumin, which is known as an active ingredient of rhizome extract, is hardly contained in konkon leaf extract. .
このようにゥコン葉エキスには、 皮膚に対する有効成分であるクルジオン、 ク ルクモールを高い割合で含有し、 さらにネオクルジオン、 タルクメノンといった 有効成分も含有しているので、 これらの有効成分の合成品や単品を含有させるよ りもゥコン葉エキスを含有させる方が便利である。 また、 従来廃棄されていたゥ コン葉の有効利用を図ることができるだけでなく、 ゥコン葉エキスに含まれてい る上記有効成分以外の成分 (テルペン類など) やミネラルに基づくプラスアルフ ァの効果も期待できる。 As described above, the konkon leaf extract contains a high proportion of the effective ingredients for the skin, such as curdion and curcumol, and also contains the effective ingredients such as neocurdione and talcumnone. It is more convenient to include konkon leaf extract than to include it. In addition to the effective use of konkon leaf that had been discarded in the past, ゥ the effect of plus alfa based on minerals (such as terpenes) and minerals other than the above-mentioned active ingredients contained in konkon leaf extract. Can be expected.
以上のような有効成分を含有するゥコン葉抽出エキスを得るために使用する 抽出溶媒としては、 供する製品の使用目的、 種類あるいは後に行う加工処理等を 考慮した上で選択すれば良いが、 通常、 水;メタノール、 エタノール、 プロピル アルコール、 ィソプロピルアルコール、 ブタノール等の低級アルコール - プロピ レングリコ一ノレ、 1 , 3 _プチレングリコール、 グリセリン等の多価アルコール; ァセトン、 メチルェチルケトン等のケトン類;酢酸ェチル、 酢酸プチル等のエス テル類;へキサン、 ヘプタン等の炭化水素類;ェチルエーテル、 テトラヒ ドロフ ラン等のエーテル類などを用いることができる。 しかし、 美白有効成分であるク ノレジオン、 タルクモール、 ネオクルジオン、 タルクメノンはいずれもへキサン等 の疎水性有機溶媒に対する溶解度が高いことから、 これらの美白成分の含有率が 高い抽出物を得るためには、 疎水性有機溶剤、 好ましくはへキサン、 ジェチルェ 一テル及び酢酸ェチルよりなる群から選択される 1種又はこれらの混合物を用 いて抽出することが好ましく、 より好ましくはへキサンである。 The extraction solvent used for obtaining the konkon leaf extract containing the active ingredient as described above may be selected in consideration of the purpose of use, the type of the product to be provided, the processing to be performed later, and the like. Water; methanol, ethanol, propyl Alcohols, lower alcohols such as isopropyl alcohol and butanol-polyhydric alcohols such as propylene glycol, 1,3-butylene glycol and glycerin; ketones such as acetone and methylethyl ketone; ethyl acetate and butyl acetate; Esters; hydrocarbons such as hexane and heptane; and ethers such as ethyl ether and tetrahydrofuran. However, knollezion, talcumol, neoculdione, and talcumenone, which are active ingredients for whitening, all have high solubility in hydrophobic organic solvents such as hexane, so that an extract with a high content of these whitening components is necessary to obtain an extract with a high content of these whitening components. Extraction is preferably performed using a hydrophobic organic solvent, preferably one selected from the group consisting of hexane, getyl ether and ethyl acetate, or a mixture thereof, and more preferably hexane.
抽出に際しては、 例えばゥコン葉粉末をメタノールで抽出した後、 さらにへキ サンで抽出するなど、 複数段階で抽出を行ってもよいが、 美白成分の含有率を高 めるために、 疎水性有機溶剤による抽出工程を含むようにすることが好ましい。 これらの溶媒で抽出したエキス含有溶液をそのまま皮膚外用剤として用いて も良いし、 必要に応じて濃縮、 希釈、 濾過、 乾燥等の処理をして用いて も良い。 また、 抽出後、 珠水性有機溶剤を乾燥等により揮発させてしまって、 美白成分の 含有率が高い粉末を得るようにしてもよい。 The extraction may be performed in multiple stages, for example, extraction of coconut leaf powder with methanol followed by extraction with hexane.However, in order to increase the content of whitening components, hydrophobic organic It is preferable to include an extraction step with a solvent. The extract-containing solution extracted with these solvents may be used as it is as an external preparation for the skin, or may be used after being subjected to treatments such as concentration, dilution, filtration, and drying as needed. After the extraction, the beaded aqueous organic solvent may be volatilized by drying or the like to obtain a powder having a high whitening component content.
一方、 エキスを抽出溶媒とともに皮膚外用剤に含有させる場合、 低級尸ルコー ル、 水又はこれらの混合物、 特に水とエタノールの混合物を抽出溶媒として用い ることが好ましい。 On the other hand, when the extract is contained in an external preparation for skin together with an extraction solvent, it is preferable to use low-grade alcohol, water or a mixture thereof, particularly a mixture of water and ethanol as the extraction solvent.
本発明の皮膚外用剤は、 クルジオン、 クルクモール、 ネオクルジオン、 タルク メノンの合成品、 天然物からの単離物、 又はゥコン葉エキスを使用し、 これらを 適当な溶媒、 基剤に含有させてもよいし、 添加剤として、 化粧品や医薬 外品に 添カ卩してもよい。 含有率は、 最終製品に応じて適宜選択される。 最終製品として は、 皮膚用薬剤や化粧水、 化粧クリームの他、 クレンジングクリーム、 クレンジ ングローション、 洗顔クリーム、 石けん等の皮膚洗浄剤;保湿化粧水、 軟化粧 水、 収斂化粧水等の整肌料; ミルキイローション、 ェモリエントミルク、 バニシ ングクリーム等の保護料;マッサージクリーム、 マッサージローション、 フォー ムパック、 ピールオフパック等の賦活料;入浴剤;パップ剤などが挙げ られる。 いずれの場合も、 経皮的に有効成分が皮膚内部に取り込まれて、 シミ、 ソバカス の退色、 低減、 消失に働くことができる。 The external preparation for skin of the present invention uses curdion, curcumol, neocurdione, a synthetic product of talc-menone, an isolated product from natural products, or konjac leaf extract, which may be contained in an appropriate solvent or base. As an additive, it may be added to cosmetics or quasi-drugs. The content is appropriately selected according to the final product. Final products include skin cleansing creams, cleansing lotions, facial cleansers, soaps, and other skin cleansing agents in addition to skin agents, lotions, and cosmetic creams; skin conditioners such as moisturizing lotions, soft lotions, and astringent lotions. Protective agents such as milky lotions, emollient milks, and vanishing creams; activators such as massage creams, massage lotions, foam packs, and peel-off packs; bath salts; and poultices. In each case, the active ingredient is transdermally incorporated into the skin, It can work for fading, reducing and disappearing.
本発明の皮膚外用剤は、 最終製品に応じて、 抽出物の効果を損ねない範固で、 基剤、 保湿剤、 増粘剤、 界面活性剤類、 p H調整剤、 防腐剤、 香料、 保湿剤、 紫 外線吸収剤、増粘剤、色素、酸化防止剤、キレート成分を配合することができ る。 油性基剤としては、 ミツロウ、 カカオ油;カルナパロウ、 高級脂肪酸、 固形パ ラフィン、 セチルアルコール、 ステアリルアルコール等の固形状油性原料; ヮセ リン、 ラノリン等の半固形状油性原料;スクヮラン、 ォリーブ油、 ヒマシ油、 パ ーム油、 ピーナッツ油、 流動パラフィン、 ォレイン酸、 リノール酸、 ミリスチン 酸ォクチルドデシル、 シリコーン油などを用いることができる。 Depending on the final product, the skin external preparation of the present invention is a solid that does not impair the effect of the extract. It can contain humectants, UV absorbers, thickeners, dyes, antioxidants, and chelating components. Oil bases include beeswax and cocoa oil; carnapa wax, higher fatty acids, solid paraffin, solid oily raw materials such as cetyl alcohol, stearyl alcohol; semi-solid oily raw materials such as serine and lanolin; squalane, olive oil; Castor oil, palm oil, peanut oil, liquid paraffin, oleic acid, linoleic acid, octyldodecyl myristate, silicone oil and the like can be used.
水性基剤としては、 グリセリン、 ソルビトール、 ポリエチレングリコ一ノレ、 ピ ロリ ドンカルボン酸及びその塩、 コラーゲン、 ヒアルロン酸及びその塩、 コ ンド ロイチン硫酸及びその塩等の保湿剤;カルボキシメチルセルロースナトリクム、 ポリビ二/レア コール'、 キサンタンガム、 カノレボキシビニノレポリマー、 ヒ ド ロキ シプロピルセルロース、 アラビアゴム等の増粘剤などが用いられる。 Examples of the aqueous base include humectants such as glycerin, sorbitol, polyethylene glycol, pyrrolidone carboxylic acid and its salts, collagen, hyaluronic acid and its salts, chondroitin sulfate and its salts; carboxymethyl cellulose sodium, polyvinyl alcohol Thickeners such as Ni / Rare Coal ', xanthan gum, canoleboxybininole polymer, hydroxypropyl cellulose, and gum arabic are used.
界面活性剤としては、 イソステアリン酸ポリエチレングリコール、 ステア リン 酸ソルビタン、 グリセリン脂肪酸ェステル、 ポリオキシェチレンへキシルデ、"シ ルエーテル等の非ィオン型界面活性剤; ラウリル硫酸ナトリウム、 ラウリル リン 酸ナトリゥム等のァニオン型界面活性剤;塩化ステアリルジメチルベンジルアン モニゥム等のカチオン型界面活性剤;ショ糖脂肪酸エステル、 カゼインナト リウ ム、 レシチン、 コラーゲン等の天然型界面活性剤などが用いられる。 Examples of the surfactant include nonionic surfactants such as polyethylene glycol isostearate, sorbitan stearate, glycerin fatty acid ester, polyoxyethylene hexylde, and silyl ether; vanionics such as sodium lauryl sulfate and sodium lauryl phosphate; Cationic surfactants such as stearyldimethylbenzylammonium chloride; natural surfactants such as sucrose fatty acid ester, casein sodium, lecithin, and collagen are used.
p H調整剤としては、 炭酸カリウム、 炭酸水素ナトリウム、 炭酸水素アンモニ ゥム等が挙げられる。 Examples of the pH adjuster include potassium carbonate, sodium hydrogen carbonate, and ammonium hydrogen carbonate.
この他、必要に応じて添カ卩され得るものとして、パラジメチルァミノ安息香酸、 ゥロカニン酸ェチル、 ジイソプロピル桂皮酸ェチル、 2—ヒ ドロキシー 4ーメ ト キシベンゾフエノン、 サリチル酸トリエタノールァミン等の紫外線吸収剤;ュチ ルパラベン、 ブチルパラベン等の防腐剤;グリチルリチン酸誘導体、 グリチノレレ チン酸誘導体、 サリチル酸誘導体、 ヒノキチオール、 酸化亜鉛、 アラントィ ン等 の消炎剤;ノ^レミチン酸レチノール等のビタミン Α類、 リボフラビン, ニコチン 酸アミ ド等のビタミン B類、 コレカルシフエロール等のビタミン D類、 d 1 —ひ 一トコフエロール等のビタミン E類などの抗酸化剤;エリソルビン酸ナトリ ゥム. セージエキス、 パラヒ ドロキシァ二ソール等の酸化防止剤;ローヤルゼリー、 コ レステロール誘導体各種アミノ酸等の賦活剤; γ一オリザノール、 デキス トラン 硫酸ナトリゥム等の血行促進剤;チタンイェロー、 カーサミン、 ベニバナ等の色 剤;その他の植物エキスが挙げられる。 In addition, those which can be added as required, such as para-dimethylaminobenzoic acid, ethyl ethyl perocyanate, ethyl ethyl diisopropylcinnamate, 2-hydroxy-4-methoxybenzophenone, triethanolamine salicylate, etc. UV absorbers; preservatives such as ethyl paraben and butyl paraben; anti-inflammatory agents such as glycyrrhizic acid derivatives, glycinoleretinic acid derivatives, salicylic acid derivatives, hinokitiol, zinc oxide, allantoin; vitamins such as retinol noremitinate Antioxidants such as vitamin Bs such as riboflavin and nicotinic acid amide, vitamin Ds such as cholecalciferol, d1—vitamin E such as 1-tocopherol; sodium erythorbic acid. Antioxidants such as sage extract and parahydroxydisole; activators such as royal jelly and cholesterol derivatives; various amino acids; blood circulation promoters such as γ- oryzanol, dextran sodium sulfate; coloring agents such as titanium yellow, carsamin and safflower; Other plant extracts are included.
本発明の皮膚美白剤は、 皮膚外用剤のうち、 特に皮膚美白を主目的とする化粧 品又は医薬部外品で、 クルジオン 0 . 5〜 5質量%及びクルクモール 0 . 5〜5 質量%含有する。 あるいはゥコン葉エキスを、 抽出方法にもよるが 1〜2 0質 量%含有する。 ゥコン葉エキスを抽出溶媒とともに含有する場合、 皮膚への刺激 との関係から水一エタノール混合液で抽出したエキスを用いることが好ましレ、。 他の成分としては、 皮膚美白剤が化粧水の場合には精製水を用いて希釈し、 必 要に応じて、 上述の保湿剤、 増粘剤、 p H調節剤、 防腐剤、 香料、 酸化防止剤、 界面活性剤、 紫外線吸収剤などを含有させればよい。 また、 化粧クリームゃクレ ンジングクリーム等の半固体状、 ジ ル状の場合には、 精製水に代えて、 適宜油 性基剤及び水性基剤を用いればよい。 実施例 The skin whitening agent of the present invention is a cosmetic or quasi-drug mainly for skin whitening, among skin external preparations, and contains 0.5 to 5% by mass of curdion and 0.5 to 5% by mass of curcumol. . Alternatively, konkon leaf extract is contained in an amount of 1 to 20% by mass, depending on the extraction method.ゥ When konkon leaf extract is contained together with an extraction solvent, it is preferable to use an extract extracted with a water-ethanol mixture because of its relationship with skin irritation. As other ingredients, if the skin lightening agent is a lotion, it is diluted with purified water, and if necessary, the above-mentioned humectant, thickener, pH regulator, preservative, fragrance, oxidation What is necessary is just to contain an inhibitor, a surfactant, an ultraviolet absorber, etc. In the case of a semi-solid or gel-like cosmetic cream / cleansing cream, an oily base and an aqueous base may be used as appropriate instead of purified water. Example
〔ゥコンエキスの調製〕 [Preparation of konkon extract]
ゥコン葉抽出液 N o . 1 : ゥ Container leaf extract No. 1:
沖絹産の春ゥコンの葉粉末を 3 0 %エタノール中に 2日間浸漬した後、 濾過し た。残查を再び 3 0 %エタノールで 2日間浸漬して、濾過した。得られた濾液(ェ タノール抽出液) を、減圧濃縮した後、 8 0 °Cで加熱殺菌し、冷却後、濾過して、 ゥコン葉エキスを得た。 このゥコン葉エキス 2 0 0 gを 3 0 %エタノール水に溶 解して 1 リ ッ トルの溶液とした (ゥコン葉エキス含有率 2 0 %) 。 The leaf powder of spring corn, produced by Oki Silk, was immersed in 30% ethanol for 2 days and then filtered. The residue was immersed again in 30% ethanol for 2 days and filtered. The obtained filtrate (ethanol extract) was concentrated under reduced pressure, sterilized by heating at 80 ° C, cooled, and filtered to obtain a corn leaf extract. 200 g of this konkon leaf extract was dissolved in 30% ethanol water to make a 1 liter solution (containment of konkon leaf extract: 20%).
ゥコン葉抽出液 N o . 2 : ゥ Contain leaf extract No 2:
山川町の春ゥコンの葉粉末 7 0 0 gをへキサン 4リットル中に 2日間浸漬し た後、 濾過した。 残查を再びへキサン 4リットルで 2日間浸漬して、 濾過した。 得られた濾液 (へキサン抽出液) を、 減圧濃縮して、 ゥコン葉エキスを得た。 ゥコン根抽出液: 700 g of leaf powder of Shunkon, Yamakawa-cho, was immersed in 4 liters of hexane for 2 days, and then filtered. The residue was immersed again in 4 liters of hexane for 2 days and filtered. The obtained filtrate (hexane extract) was concentrated under reduced pressure to obtain a corn leaf extract.ゥ Conn root extract:
沖艉産の春ゥコンの根粉末を 3 0 %エタノール中に 2日間浸漬した後、 濾過し た。残查を再び 3 0 %エタノールで 2日間浸漬して、濾過した。得られた濾液(ェ タノール抽出液) を、減圧濃縮した後、 80°Cで加熱殺菌し、冷却後、濾過して、 ゥコン根エキスを得た。 このゥコン根エキス 200 gを 30%エタノール水に溶 解して 1 リットルの溶液とした (ゥコン根エキス含有率 20%) 。 The root powder of spring corn produced in Oki was immersed in 30% ethanol for 2 days and then filtered. The residue was immersed again in 30% ethanol for 2 days and filtered. The resulting filtrate (e) The ethanol extract was concentrated under reduced pressure, sterilized by heating at 80 ° C, cooled, and filtered to obtain a root extract. 200 g of the konkon root extract was dissolved in 30% ethanol water to make a 1 liter solution (20% konkon root extract content).
〔活性酸素除去効果〕 (Active oxygen removal effect)
ゥコン葉抽出液 N o. 1及びゥコン根抽出液について、 活性酸素除去機" を、 NBT試験により測定した。 The active oxygen remover was measured for N. leaf extract No. 1 and N. root extract by NBT test.
NBT試験は、 発色試薬 (ニトロブルーテトラゾリゥム (NBT) 0. 24m Mとキサンチン 0. 4mMを含有する pH8. 0のリン酸緩衝液) と酵素液 (0. 049U/mlのキサンチノキシダーゼ含有) を試料液に加え、 第 2図に す反 応により生じるジホルマザンの生成量を測定することにより、 キサンチン (O酸化 により生じた活性酸素ラジカルの消去量を調べる試験である。 試料から発 する 水素イオン (活性酸素ラジカル除去機能) が多いほど、 NBTがジホルマザンに 変化する量が減少する。 The NBT test consists of a coloring reagent (phosphate buffer of pH 8.0 containing 0.24 mM of nitro blue tetrazolium (NBT) and 0.4 mM of xanthine) and an enzyme solution (0.049 U / ml of xanthinoxidase). Is added to the sample solution, and the amount of diformazan generated by the reaction shown in Fig. 2 is measured to determine the amount of xanthine (the active oxygen radicals generated by O-oxidation). The more hydrogen ions (active oxygen radical scavenging function), the smaller the amount of NBT converted to diformazan.
ゥコン葉抽出液 N o . 1又はゥコン根抽出液 10 μ 1に、 発色試薬 10 Ο μ 1 を添加して、 ミキサ一で 1分間攪拌した後、 酵素液 100 1添カロして、 L分間 攪拌して、 37 °Cで 28分間加温した。 その後、 反応停止液 (ドデシル硫 ナト リウム 69 OmM) を 20 μ 1添カ卩し、 5分間攪拌して、 反応を停止させすこ。 5 60 nmでの吸光度 Esを測定した。 1 ゥ konkon leaf extract No. 1 or 10 μl of konkon root extract, add 10 Ομ1 of the coloring reagent, stir with a mixer for 1 minute, add 100 l of enzyme solution, add stirring, and stir for L minutes Then, the mixture was heated at 37 ° C. for 28 minutes. Then, add 20 μl of a reaction stop solution (sodium dodecyl sulfate 69 OmM), and stir for 5 minutes to stop the reaction. The absorbance E s at 5 60 nm was measured.
酵素液に代えて、プランク液として蒸留水 100 1を用いて、同様に行って、 560 nmでの吸光度 ESB 1を測定した。 Instead of the enzyme solution, using distilled water 100 1 as Planck liquid, similarly performed on the absorbance was measured E SB 1 in 560 nm.
コントロールとして、 試料水溶液に代えて蒸留水 10 μ 1を用いて、 酵赛液を 添加した場合の 560 n inでの吸光度 (EB 1) 及び酵素液の代わりにブラ ク液 を用いた場合の 56011111での吸光度£]^1を測定した。 As a control, the absorbance at 560 nin (EB 1 ) when the enzyme solution was added using 10 μl of distilled water instead of the sample aqueous solution and the black solution was used instead of the enzyme solution absorbance at 56011111 £] ^ 1 was measured.
測定した吸光度から、 下式に基づいて、 活性酸素除去率を求めた。 From the measured absorbance, the active oxygen removal rate was determined based on the following equation.
活性酸素除去率 = U— (ES-ESB1) ÷ (EB1— EBB1) } xl 00 ゥコン葉抽出液 N o . 1の活性酸素除去率は 34. 4 %であり、 ゥコン の活 性酸素除去率は 63%であった。 ゥコン葉エキスの活性酸素除去機能は、 ク コン 根エキスに比べて低いといえる。 ゥコン根エキスには、 水素イオンを発生するク ルクミンを含有しているが、 ゥコン葉エキスの主成分であるクルジオン、 クノレク モールには、 ヒド口キシラジカルの発生が期待できないからと考えられる。 〔チロシナーゼ活性阻害作用〕 Active oxygen removal rate = U— (E S -E SB1 ) ÷ (E B1 — E BB1 )} xl 00 ゥ Container leaf extract No. 1 has an active oxygen removal rate of 34.4%, indicating that the activity of ゥThe oxygen removal rate was 63%.ゥ It can be said that the active oxygen removal function of konkon leaf extract is lower than that of konkon root extract.ゥ Concrete root extract contains curcumin, which generates hydrogen ions. ク ル It is probable that cruzione and knorecmol, which are the main components of konkon leaf extract, are not expected to generate any x-radicals. (Tyrosinase activity inhibitory action)
ゥコン葉抽出液 No. 1及ぴゥコン根抽出液について、 メラニンの生成に関与 する酵素であるチロキシナーゼ活性の阻害作用を調べた。 The konkon leaf extract No. 1 and the konkon root extract were examined for their inhibitory effect on the activity of tyroxynase, an enzyme involved in melanin production.
測定は、 チ口シナーゼ酵素液 ( 0. 1単位 Zm g、 10%) と、 基質として L -DOP A (Lージヒドロキシフエ二ルァラニン) を pH6〜6. 2に保持する リン酸緩衝液 ( 1 Z 1 5 Mの N a 2HP O 4溶液 200m lと lZl 5 Mの KH2 P04溶液 800m lの混合液) に溶解させた溶液を使用し、 試料液を添カ卩して、 ドーパキノンの生成量を測定することにより行った。 L— DOPAは、 第 1図に 示すように反応して、 メラニン生成の元となるドーパキノンを生成し、 チロシナ ーゼ酵素は、 この反応に関与している。 従って、 試料がチロシナーゼ酵素反応を 阻害することにより、 ドーパキノン生成量を低下させ、 結果としてメラニンの生 成を抑制することができる。 The measurement was carried out using an enzyme solution (0.1 unit Zmg, 10%) and a phosphate buffer solution (L-DOPA (L-dihydroxyphenylalanine)) maintained at pH 6-6.2 as a substrate. using the Z 1 5 M of N a 2 HP O 4 solution 200 meters l and lZl 5 M of KH 2 P0 4 solution 800m solution was dissolved in a mixture) of l, the sample solution was添Ka卩, the dopaquinone This was performed by measuring the amount of production. L-DOPA reacts as shown in Fig. 1 to produce dopaquinone, a source of melanin production, and tyrosinase enzymes are involved in this reaction. Therefore, the sample inhibits the tyrosinase enzyme reaction, thereby reducing the amount of dopaquinone produced and consequently the melanin production can be suppressed.
具体的には、 チロシナーゼ酵素液として、 ジャガイモ塊茎から調製したァセト ンパゥダー 1 gに、 リン酸緩衝液 10 m 1をカロえて得られる懸濁液を吸引濾過し て得られた濾液を用いた。 Specifically, as the tyrosinase enzyme solution, a filtrate obtained by subjecting a suspension obtained by calorizing a phosphate buffer solution to 10 g of phosphate buffer to 1 g of acetone powder prepared from potato tubers to obtain a suction solution was used.
試料液であるゥコン葉抽出液 N o. 1又はゥコン根抽出液 20 μ 1に、 基質溶 液 100 1と酵素液 20 μ 1を添カ卩して混合し、 30°Cで 1 5分間反応させた 後、 反^停止液として 0. 1 N塩酸を 20 μ 1添加した。 Add 1 μl of substrate solution and 20 μl of enzyme solution to 20 μl of konkon leaf extract No. 1 or 20 μl of konkon root extract, which are sample liquids, mix and react at 30 ° C for 15 minutes After that, 20 μl of 0.1 N hydrochloric acid was added as an anti-stop solution.
反応後の液について、 400 nmで吸光度 (S) を測定した。 After the reaction, the absorbance (S) was measured at 400 nm.
なお、 ブランクとして、 試料液及び基質に代えてリン酸緩衝液を使用して、 4 O O nmで吸光度 (B) を測定した。 下式により、 チロシナーゼ阻害率を算出し た。 The absorbance (B) was measured at 40 nm using a phosphate buffer instead of the sample solution and the substrate as a blank. The tyrosinase inhibition rate was calculated by the following equation.
チロシナーゼ阻害率 = (B-S) /Β 100 Tyrosinase inhibition rate = (B-S) / Β100
ゥコン葉抽出液 Ν ο. 1のチロシナーゼ活性阻害率は 14. 9 %であり、 ゥコ ン根エキスのチロシナーゼ活性阻害率は 7. 7%であった。 ゥコン葉抽出液は、 ゥコン根抽出液の約 2倍のチロシナーゼ活性阻害作用を有することがわかる。 The tyrosinase activity inhibition rate of ゥ kon leaf extract 液 ο.1 was 14.9% and the tyrosinase activity inhibition rate of ゥ konkon root extract was 7.7%. It can be seen that the ゥ kon leaf extract has about twice the tyrosinase activity inhibitory effect of the ゥ kon root extract.
〔抽出方法の違いによるゥコン葉エキスとチロシナーゼ活性阻害作用の関係〕 ゥコン葉抽出液 No. 1について、 へキサンと水で分液し、 へキサン画分と水 画分の双方について、 チロシナーゼ活性阻害率を上記方法と同様にした測定した。 へキサン画分のチロシナーゼ活性阻害率は 46. 9%であったのに対し、 水画 分は一 3 8%であった。 へキサン画分ではゥコン葉抽出液 No. 1と比べてラロ シナーゼ活性阻害が増大したのに対し、 水画分ではチロシナーゼ活性を促進する という逆転現象が認められた。 [Relationship between konkon leaf extract and tyrosinase activity inhibitory effect due to differences in extraction methods] ゥ Separate konkon leaf extract No. 1 with hexane and water, and inhibit tyrosinase activity for both hexane and water fractions. The ratio was measured in the same manner as described above. The tyrosinase activity inhibition rate of the hexane fraction was 46.9%, whereas the water fraction The minute was 38%. In the hexane fraction, the inhibition of larosinase activity was increased as compared with the radish leaf extract No. 1, whereas in the water fraction, the reversal phenomenon of promoting tyrosinase activity was observed.
〔ゥコン葉へキサン抽出^に含まれる有効成分の同定〕 [Identification of active ingredients contained in ゥ cone leaf hexane extraction ^]
ゥコン葉抽出液 No. 2をガスクロマトグラフィーにかけたところ、 第 3図に 示すような結果が得られた。 第 3図に表れるピーク 1、 2、 3、 6に該当する成 分を分離し、 マススぺク トル分析及び NMR分析、 及び融点を測定した。 ピ——ク 成分 2のマススペク トル (条件: GC E I ) は第 4図に示す通りで、 クルジォ ンであることを同定した。 ピーク成分 6のマススペク トル (条件: G C E I ) は第 5図に示す通りで、 タルクモールであることを同定した。 ピーク成分 1のマ ススペク トル (条件: G C C I ) は第 6図に示す通りで、 タルクメノンで る ことを同定した。 ピーク成分 3のマススぺク トル (条件: G C C I ) は第つ図 に示す通りで、 ネオクルジオンであることを同定した。 (4) Gas chromatographic analysis of corn leaf extract No. 2 gave the results shown in Fig. 3. Components corresponding to peaks 1, 2, 3, and 6 shown in FIG. 3 were separated, and mass spectrum analysis and NMR analysis and melting point were measured. The mass spectrum of peak component 2 (conditions: GCEI) was as shown in Fig. 4, and it was identified that it was a cruzion. The mass spectrum of peak component 6 (condition: GCE I) was as shown in FIG. 5, and it was identified as talcumol. The mass spectrum (condition: GCCI) of peak component 1 was as shown in FIG. 6, and it was identified as talcummenone. The mass spectrum of the peak component 3 (condition: GCCI) is as shown in Fig. 1, and it was identified as neocludione.
〔ゥコン葉抽出液に含まれる有効成分のチロシナーゼ阻害活性及び S OD活 性〕 [ゥ Tyrosinase inhibitory activity and SOD activity of active ingredients contained in corn leaf extract]
山川町の春ゥコン葉を、 ゥコン葉抽出液 No. 1と同様にしてエタノール 由出 物 1 7 9 gを得、この抽出物をさらにへキサンと水で分液し、へキサン画分( O . 64 g) と水画分 (1 50. 6 g) を得た。 さらにへキサン画分をシリカゲル (富 士シリジァ化学の BW— 1 2 7 Z H) を充填したカラムを用いてクロマトグラフ ィーを行った。 はじめにへキサンと酢酸ェチルを 3 : 1で混合した溶剤を用レ、て 3つのフラクションに分画し (フラクション 1 : 0. 2 g、 フラクション 2 : O. 04 g、 フラクション 3 : 0. 1 2 g ) 、 フラクション 1からクルクメノ Z 0. 2 g、 フラクション 2からクルジオン 0. 0 3 gを得た。 In the same manner as in the coconut leaf extract No. 1, 179 g of an ethanol-derived product was obtained from the spring corn leaf in Yamakawa Town, and this extract was further separated with hexane and water to obtain a hexane fraction (O 64 g) and a water fraction (1500.6 g). The hexane fraction was chromatographed using a column packed with silica gel (BW-127ZH from Fuji Shirijia Chemical). First, a mixture of hexane and ethyl acetate in a ratio of 3: 1 was used to separate the fractions into three fractions (fraction 1: 0.2 g, fraction 2: O. 04 g, fraction 3: 0.12) g), 0.2 g of curcumeno Z from fraction 1 and 0.03 g of curdione from fraction 2.
次に、 フラクション 3をシリカゲルクロマトグラフィーにかけ、 へキサンと酢 酸ェチルを 1 0 : 1で混合した溶剤を用いて 3つのフラクションに分画し (フラ クシヨン 4 : 24mg、フラクション 5: 1 5mg、 フラクション 6 : 2 9 m g〕、 フラクション 4からネオクルジオン 1. 2mg、 フラクション 5からクルクモー ノレ 1 2 m gを得た。 Next, fraction 3 was subjected to silica gel chromatography and fractionated into three fractions using a solvent in which hexane and ethyl acetate were mixed at a ratio of 10: 1 (fraction 4:24 mg, fraction 5:15 mg, fraction 5:15 mg, 6:29 mg], 1.2 mg of neocurdione from fraction 4, and 12 mg of curcumonele from fraction 5.
上記で分画した各フラクシヨンのチロシナーゼ阻害活性及び S O D活性を上 記方法に従って測定した。 結果を第 8図に示す。 また、各フラクションから単離したクルジオン、タルクモール、クノ クメノン、 ネオクルジオンについて、 濃度とチロシナーゼ活性の関係を調べた。 結果を表 1 に示す The tyrosinase inhibitory activity and the SOD activity of each fraction fractionated above were measured according to the above-mentioned methods. The results are shown in FIG. In addition, the relationship between concentration and tyrosinase activity was investigated for culdione, talcumol, kunocumenone, and neoculdione isolated from each fraction. The results are shown in Table 1.
表 1 table 1
表 1から、 いずれの成分も高いチロシナーゼ阻害活性を示し、 美白成分として 有用であることが確認できた。 従って、 クルジオン及びクルクモーノレを主成分と し、 さらにネオクルジオン、 タルクメノンを含有するゥコン葉エキスは、 高い美 白効果を期待できる。 From Table 1, it was confirmed that each of the components exhibited high tyrosinase inhibitory activity and was useful as a whitening component. Accordingly, a konkon leaf extract containing curdione and curcumonele as main components and further containing neocurdione and talcumnone can be expected to have a high whitening effect.
〔ゥコン葉主成分の単離とチロシナーゼ阻害活性〕 [ゥ Isolation of konkon leaf main component and tyrosinase inhibitory activity]
1 gのゥコン葉抽出液 N o . 2を、シリカゲルを充填したカラムに: a入した後、 へキサンと酢酸ェチル混合液 (へキサン:酢酸ェチル 3 : 1 ) 、 酢酸ェチル、 ク ロロホルム、 メタノールの順で、 展開、 溶出した。 得られた溶出液 ( 成分を検索 したところ、 クルジオンはへキサンと酢酸ェチルの混合液画分に含おれ、 タルク モールは酢酸ェチル画分に含まれることがわかった (純度 9 0 %以_^) 。 After putting 1 g of coconut leaf extract No. 2 into a column packed with silica gel: a, a mixture of hexane and ethyl acetate (hexane: ethyl acetate 3: 1), ethyl acetate, chloroform, methanol In this order, it evolved and eluted. The eluate obtained was analyzed for its components, and it was found that crudion was contained in the mixed liquid fraction of hexane and ethyl acetate, and talcumol was contained in the ethyl acetate fraction (purity 90% or less_ ^ ).
上記へキサンと酢酸ェチルの混合液画分、 及び酢酸ェチル画分の容媒を留去し たところ、 白色結晶が得られた。 クルジオンの収量は 0 . 3 7 §で¾?り、 タルク モールの収量は 0 . 2 3 gであった。 When the solvent of the above-mentioned mixed solution fraction of hexane and ethyl acetate and the solvent of the ethyl acetate fraction were distilled off, white crystals were obtained. The yield of crudion was 0.37 § and the yield of talcumol was 0.23 g.
クルジオン及びタルクモールの各白色結晶について、 チロシナーゼ活性を上記 方法に準じて測定した。 尚、 これらの結晶はいずれも水に溶解しな;^つたので、 少量のジメチルスルフォキシド (D I M S O) に溶解した後、 水に; Θ·散させて試 料液とした。 The tyrosinase activity of each of the white crystals of Culdione and Talcmol was measured according to the method described above. Note that none of these crystals was soluble in water; they were dissolved in a small amount of dimethyl sulfoxide (DIMSO) and then dispersed in water to form a sample solution.
クルジオン液のチロシナーゼ阻害活性は 6 2 . 1 %、 タルクモーノレ液のチロシ ナーゼ阻害活性は 5 5 . 4 %であった。 〔化粧水としての効果〕 The tyrosinase inhibitory activity of the Culdione solution was 62.1%, and the tyrosinase inhibitory activity of the talcumone solution was 55.4%. [Effect as lotion]
ゥコン抽出液 N o . 1を精製水で希釈して、 ゥコン葉エキス 2 %の化粧水を調 製した。 The corn extract No. 1 was diluted with purified water to prepare a 2% lotion of konkon leaf extract.
この化粧水を、 朝の洗顔後で化粧前に、 及び夜の洗顔後につける化粧水の代わ りとして 6人のパネラーに、 2ヶ月間使用してもらったところ、 以下のような結 果を得た。 Six panelists used this lotion for two months instead of applying it after washing in the morning, before makeup, and after washing in the evening.The following results were obtained. Was.
ノ ネラー 1 ( 2 4歳の女性) シミが薄くなり、 肌が白くなつた None 1 (24-year-old woman) Stain became thin and skin became white
パネラー 2 ( 6 0歳の女性) シミが薄くなった Paneler 2 (60-year-old woman)
パネラー 3 ( 5 9歳の女性) シミが 2ヶ月程度で半分以下になった。 Paneler 3 (five-year-old woman) Spots decreased to less than half in about two months.
パネラー 4 ( 4 6歳の男性) ソバカスが 1ヶ月程度で 1 Z 4程度にまで減少 した。 Paneler 4 (male aged 46) Sobacas decreased to around 1Z4 in about one month.
パネラー 5 ( 3 7歳の女性) 毛穴の黒ずみがなくなった。 Paneler 5 (37-year-old woman) The pores are no longer darkened.
パネラー 6 ( 3 1歳の女性) 湿疹や二キビの芯が膿んだりすることなく、 と れてきた。 Paneler 6 (31-year-old woman) Eczema and acne core came off without pus.
パネラー 1〜4の結果からわかるように、 本発明の化粧水は、 シミ、 ソバカス の退色、 低減、 消去に効果がある。 また、 パネラー 5については、 シミ、 ソバカ スではないが、 本発明の化粧水により黒ずみが減り、 色素退色といった美白効果 があることがわかる。 As can be seen from the results of panelists 1-4, the lotion of the present invention is effective in fading, reducing and eliminating stains and freckles. Paneler 5 is not a stain or buckwheat, but it can be seen that the skin lotion of the present invention has a whitening effect such as reduced blackening and pigment fading.
パネラー 6については、 色素退色といった美白効果ではないが、 ゥコン葉の抽 出物の抗菌効果によるものではないかと考えられる。 Paneler 6 does not have a whitening effect such as pigment fading, but it is thought to be due to the antibacterial effect of the extract of konkon leaf.
〔抗菌効果〕 (Antibacterial effect)
熊本産ゥコン葉粉末 7 0 0 gをメタノール 4 リ ッ トルで 2 4時間、 室温で抽出 し、 これを濾過して、 メタノール抽出液と残查に分けた。 この残查を、 再度 4リ ットルのメタノールに浸し、 同様に濾過した後、 再度この残查に対してメタノー ル抽出を行った。 得られたこれらのメタノール抽出液をまとめて減圧濃縮し、 1 2 2 . 1 gのメタノール抽出物を得た。 700 g of konkon leaf powder from Kumamoto was extracted with 4 liters of methanol at room temperature for 24 hours, filtered, and separated into a methanol extract and a residue. The residue was immersed again in 4 liters of methanol, filtered in the same manner, and then subjected to methanol extraction again. The obtained methanol extracts were combined and concentrated under reduced pressure to obtain 122. 1 g of a methanol extract.
得られたメタノール抽出物をへキサン 1 リットルを用いてへキサン層とメタ ノール層とに分液し、 それぞれの層を減圧濃縮して、 3 8 . 7 9 7 1 gのへキサ ン抽出物と 4 9 . 9 3 8 gのメタノール抽出物に分けた。 へキサン抽出物とメタ ノール抽出物の双方について、 ペーパーディスク法で、 大腸菌を指標として抗菌 活性を調べたところ、 メタノール抽出物には抗菌活性は認められず、 へキサン抽 出物に抗菌活性が認められた。 The obtained methanol extract was separated into a hexane layer and a methanol layer using 1 liter of hexane, and each layer was concentrated under reduced pressure to obtain 38.7971 g of the hexane extract. And 49.938 g of methanol extract. Antibacterial activity of both hexane and methanol extracts by paper disk method using E. coli as an indicator When the activity was examined, no antibacterial activity was observed in the methanol extract, and antibacterial activity was observed in the hexane extract.
次いで、 へキサン抽出物を水蒸気蒸留して、 精油成分 0 . 3 2 3 gを得た。 こ の精油成分を用いて、 大腸菌を指標に、 マイクロプレート法でマイナスコント口 ールに D M S〇、 ポジティブコントロールに安息香酸を用いて抗菌試験を行った ところ、 安息香酸と同程度の抗菌性を示した。 Then, the hexane extract was subjected to steam distillation to obtain 0.323 g of an essential oil component. Using this essential oil component, an antibacterial test was performed using Escherichia coli as an indicator, DMS〇 as a negative control using a microplate method, and benzoic acid as a positive control. Indicated.
このへキサン抽出成分をシリカゲルクロマトグラフィーを后いて、 クルジオン 含有フラクション及びクルクモール含有フラクションを得た。 各フラクションに ついて、 ペーパーディスク法及びマイクロプレート法で、 各種菌に対する抗菌活 性を調べた。 結果を表 2 (ペーパーディスク法) 及び表 3 (マイクロプレート法) に示す。 The hexane extract was subjected to silica gel chromatography to obtain a curdion-containing fraction and a curcumol-containing fraction. For each fraction, antibacterial activity against various bacteria was examined by the paper disk method and the microplate method. The results are shown in Table 2 (paper disc method) and Table 3 (microplate method).
表中、 「十」 は抗菌活性があることを示し、 その数が多い稳、 活性が強いこと を示している。 「一」 は抗菌活性がないことを示している。 In the table, “ten” indicates that the substance has antibacterial activity, and the number is large, indicating that the activity is strong. "One" indicates no antimicrobial activity.
表 2 Table 2
供試菌株 クルジオン クノレクモール Test strain Crudion Knorecmol
Bacillis subtilis + + + + + + Bacillis subtilis + + + + + +
Flavobactirium lutescens + + + + Flavobactirium lutescens + + + +
Escherichia coli + + + + + Escherichia coli + + + + +
Micrococcus luteus + + Micrococcus luteus + +
Pseudomonas aeruginosa + + Pseudomonas aeruginosa + +
Aspergillus flavus ― ― Aspergillus flavus ― ―
Aspergillus niger + + Aspergillus niger + +
Aspergillus japonicus ― ― Aspergillus japonicus ― ―
Aspergillus oryzae + + + Aspergillus oryzae +++
Aspergillus sojae ― 一 Aspergillus sojae ― Ichi
Fusarium solani + + + Fusarium solani + + +
F sarium oxysporum + + + F sarium oxysporum + + +
Saccharomyces cerevisiae + + 表 3 Saccharomyces cerevisiae ++ Table 3
表 2及び表 3の結果から、 クルジオン及びタルクモールの含有率は、 種々のバ クテリァ及び一部の力ビについて、 抗菌活性を有することが確認できた。 産業上の利用可能性 From the results shown in Tables 2 and 3, it was confirmed that the content of cruzione and talcumol had antibacterial activity for various bacterium and some power plants. Industrial applicability
本発明の皮膚外用剤は、 高いチロシナーゼ活性阻害作用を有し、 また抗菌活性 を有しているので、 美白用化粧品をはじめ、 二キビ、 しみの防止、 治療を目的と する皮膚外用剤として用いることができる。 Since the skin external preparation of the present invention has a high tyrosinase activity inhibitory activity and also has an antibacterial activity, it is used as a skin external preparation for the purpose of whitening cosmetics, prevention of acne and spots and treatment. be able to.
Claims
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2004/002766 WO2005084613A1 (en) | 2004-03-04 | 2004-03-04 | Skin preparation for external use |
| JP2006510577A JPWO2005084613A1 (en) | 2004-03-04 | 2004-03-04 | Skin preparation |
| TW093106146A TW200529874A (en) | 2004-03-04 | 2004-03-09 | Skin preparation for external use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2004/002766 WO2005084613A1 (en) | 2004-03-04 | 2004-03-04 | Skin preparation for external use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2005084613A1 true WO2005084613A1 (en) | 2005-09-15 |
Family
ID=34917827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2004/002766 Ceased WO2005084613A1 (en) | 2004-03-04 | 2004-03-04 | Skin preparation for external use |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2005084613A1 (en) |
| TW (1) | TW200529874A (en) |
| WO (1) | WO2005084613A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008137931A (en) * | 2006-11-30 | 2008-06-19 | Yamazaki Arata | Spring turmeric leaf extract, cosmetics and food |
| WO2010053340A3 (en) * | 2008-11-10 | 2010-07-08 | 주식회사 알엔에스 | Skin-whitening composition |
| WO2011158333A1 (en) * | 2010-06-15 | 2011-12-22 | 株式会社ナリス化粧品 | Zederone analogue and method for synthesizing same |
| JP2017171584A (en) * | 2016-03-18 | 2017-09-28 | 日油株式会社 | Composition comprising defatted rice bran extract |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61291515A (en) * | 1985-06-19 | 1986-12-22 | Shiseido Co Ltd | Cosmetic |
| JPH01233217A (en) * | 1988-03-15 | 1989-09-19 | Tsumura & Co | Diabetic treatment agent |
| JPH1121234A (en) * | 1997-07-01 | 1999-01-26 | Res Inst For Prod Dev | Antihepatitis agent |
| JP2001122765A (en) * | 2000-09-28 | 2001-05-08 | Naris Cosmetics Co Ltd | Active oxygen scavenger and cosmetic |
| JP2001163793A (en) * | 1999-12-07 | 2001-06-19 | Keigo Kusano | Method for deodorizing offensive smell of plant rhizome, and deodorizing and reducing bitter component by vegetable component |
| JP2002027947A (en) * | 2000-07-17 | 2002-01-29 | Keigo Kusano | Active use of plant stem and leaf as unused resources, and method for producing the plant stem and leaf |
| JP2002284634A (en) * | 2001-03-28 | 2002-10-03 | Akinori Komatsu | Cosmetic liquid |
| JP2003137799A (en) * | 2001-03-28 | 2003-05-14 | Kiyotoshi Oshiro | Diacylglycerol solution including turmeric and method for producing the same |
| JP2003160461A (en) * | 2001-11-21 | 2003-06-03 | Shiseido Co Ltd | Skin care preparation |
| JP2003292432A (en) * | 2002-04-04 | 2003-10-15 | Noevir Co Ltd | Skin care preparation |
| JP2004131498A (en) * | 2002-09-18 | 2004-04-30 | Veritas:Kk | External preparation for skin |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002212052A (en) * | 2001-01-15 | 2002-07-31 | Hajime Ito | External preparation |
| JP2005239697A (en) * | 2004-02-25 | 2005-09-08 | Nozaki Katsunori | Skin lotion |
-
2004
- 2004-03-04 WO PCT/JP2004/002766 patent/WO2005084613A1/en not_active Ceased
- 2004-03-04 JP JP2006510577A patent/JPWO2005084613A1/en active Pending
- 2004-03-09 TW TW093106146A patent/TW200529874A/en unknown
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61291515A (en) * | 1985-06-19 | 1986-12-22 | Shiseido Co Ltd | Cosmetic |
| JPH01233217A (en) * | 1988-03-15 | 1989-09-19 | Tsumura & Co | Diabetic treatment agent |
| JPH1121234A (en) * | 1997-07-01 | 1999-01-26 | Res Inst For Prod Dev | Antihepatitis agent |
| JP2001163793A (en) * | 1999-12-07 | 2001-06-19 | Keigo Kusano | Method for deodorizing offensive smell of plant rhizome, and deodorizing and reducing bitter component by vegetable component |
| JP2002027947A (en) * | 2000-07-17 | 2002-01-29 | Keigo Kusano | Active use of plant stem and leaf as unused resources, and method for producing the plant stem and leaf |
| JP2001122765A (en) * | 2000-09-28 | 2001-05-08 | Naris Cosmetics Co Ltd | Active oxygen scavenger and cosmetic |
| JP2002284634A (en) * | 2001-03-28 | 2002-10-03 | Akinori Komatsu | Cosmetic liquid |
| JP2003137799A (en) * | 2001-03-28 | 2003-05-14 | Kiyotoshi Oshiro | Diacylglycerol solution including turmeric and method for producing the same |
| JP2003160461A (en) * | 2001-11-21 | 2003-06-03 | Shiseido Co Ltd | Skin care preparation |
| JP2003292432A (en) * | 2002-04-04 | 2003-10-15 | Noevir Co Ltd | Skin care preparation |
| JP2004131498A (en) * | 2002-09-18 | 2004-04-30 | Veritas:Kk | External preparation for skin |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008137931A (en) * | 2006-11-30 | 2008-06-19 | Yamazaki Arata | Spring turmeric leaf extract, cosmetics and food |
| WO2010053340A3 (en) * | 2008-11-10 | 2010-07-08 | 주식회사 알엔에스 | Skin-whitening composition |
| WO2011158333A1 (en) * | 2010-06-15 | 2011-12-22 | 株式会社ナリス化粧品 | Zederone analogue and method for synthesizing same |
| JP2017171584A (en) * | 2016-03-18 | 2017-09-28 | 日油株式会社 | Composition comprising defatted rice bran extract |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2005084613A1 (en) | 2008-01-17 |
| TW200529874A (en) | 2005-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4489923B2 (en) | Topical skin preparation | |
| JP2009029734A (en) | External preparation for skin | |
| JP2004131498A (en) | External preparation for skin | |
| JP2008273922A (en) | External preparation for skin and external preparation for mucosa | |
| JPH11286423A (en) | Composition for suppressing body odor | |
| EP3990123A1 (en) | Skin care composition | |
| JP4824181B2 (en) | Topical skin preparation | |
| WO2005084613A1 (en) | Skin preparation for external use | |
| JP3584489B2 (en) | External preparation for skin | |
| JP2002121144A (en) | Skin care preparation | |
| JP5713517B2 (en) | Spring turmeric leaf extract and cosmetics | |
| JPS61194008A (en) | Cosmetic | |
| JP2002234828A (en) | Skin whitening cosmetic preparation | |
| JP4076477B2 (en) | Skin preparation | |
| JP2003095857A (en) | Skin care preparation | |
| JP2982872B1 (en) | External preparation for slimming skin | |
| JP2010215516A (en) | Skin care preparation for external use and mucous membrane preparation for external use | |
| JP2004203777A (en) | Ageing-preventing and improving cosmetic | |
| JP4402274B2 (en) | Topical skin preparation | |
| JP2002029920A (en) | Bleaching cosmetic | |
| JPH11171722A (en) | Preparation for external use for skin | |
| JP5468866B2 (en) | Topical skin preparation | |
| JP5415216B2 (en) | Topical skin preparation | |
| JPH10203922A (en) | Cosmetic | |
| JP2002154945A (en) | Bleaching skin preparation for external use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2006510577 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
| 122 | Ep: pct application non-entry in european phase |